首頁
SV Health Investors

8月 2026SV Health Investors的市場佔有率分析

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

金融 > 投資

域名svhealthinvestors.com

成立年份1993

僱員51 - 200

年度營收$25M - $50M

SV Health Investors

SV Health Investors（包含公司地區）

svhealthinvestors.com

查看更多網站流量與參與度資訊

SV Health Investors截至 8月 2026 的總收入為 25M - 50M

SV Health Investors 熱門網域產生的總收入

SV Health Investors 熱門網域 3 年內的總收入

SV Health Investors 熱門網域的總收入

svhealthinvestors.com25M - 50M

透過銷售情報查看更多內容

SV Health Investors的熱門網域總造訪量

了解SV Health Investors市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

svhealthinvestors.com11.3K

透過銷售情報查看更多內容

SV Health Investors的熱門網域平均造訪時長

分析SV Health Investors參與度指標。

過去 3 個月平均造訪時長

子公司細目

svhealthinvestors.com00:01:45

透過銷售情報查看更多內容

SV Health Investors的熱門網域平均頁面瀏覽量

了解SV Health Investors如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

svhealthinvestors.com2.95

透過銷售情報查看更多內容

SV Health Investors按網域劃分的熱門競爭對手

8月 2026的熱門類似網站，依相似度排名

rtwfunds.com公司名RTW Investments僱員51 - 200總部美國, 紐約, New York年度營收$2M - $5M訪問總量6.2K健康 > 生物技術和製藥

使用的熱門技術SV Health Investors

这些是SV Health Investors顶级域名使用的行业网站技术

付款與貨幣 (4)

Euro

社群 (3)

Instagram

內容管理系統 (2)

WordPress

轉換與分析 (2)

Google Analytics

更多技術

9

檢視所有

新聞與訊號來自SV Health Investors

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞SV Health Investors LLP invests into Draig Therapeutics Ltd in Seed.Draig Therapeutics was co-founded by Cardiff University and SV Health Investors which led the seed financing with ICG, and is backed by other healthcare venture firms including Access Biotechnology, Canaan Partners, SR One, Sanofi Ventures and Schroders Capital.

新聞SV Health Investors LLP acquired EpiVax, Inc. on Apr 2nd '26.SV Health Investors, a healthcare and life sciences focused private investment firm, announced today the acquisition of EpiVax, Inc. Headquartered in Providence, RI, EpiVax is a leading bioanalytical CRO specializing in immunogenicity risk assessments for pharmaceutical and biotech companies.

新聞SV Health Investors LLP invested into Mestag Therapeutics Limited $40M in financing on Mar 17th '26.Cambridge, UK, March 17, 2026 - Mestag Therapeutics ("Mestag"), a biotech company harnessing fibroblast immunology to develop impactful treatments for patients with cancer and inflammatory diseases, today announced the closing of a $40 million financing supported by leading life science investors SV Health Investors, Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation - JJDC, Inc., Forbion, GV (Google Ventures) and Northpond Ventures.